Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • WDAY vs GSK✓SelectedUSD · GSKWDAY vs GSK performance historyLatest closeAs of-2.93%11/18
Stock and ETF performance explorer

WDAY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-25.1%
GSK return
+56.0%
Excess return
-81.1%
Maximum drawdown
-63.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.9%-1.3%-1.6%-2.7%
7D-7.2%-3.1%-4.0%-6.7%
30D-9.1%-0.9%-8.2%-8.9%
3M-6.9%-4.2%-2.7%-6.5%
6M+37.7%-1.6%+39.3%+38.2%
YTD-17.4%+2.6%-20.0%-18.5%
1Y-21.4%+6.2%-27.6%-22.9%
All-25.1%+56.0%-81.1%-29.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling